| MeSH term | MeSH ID | Detail |
|---|---|---|
| Malocclusion | D008310 | 3 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Leukemia | D007938 | 74 associated lipids |
| Neuroblastoma | D009447 | 66 associated lipids |
| Carcinoma, Hepatocellular | D006528 | 140 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Periodontal Diseases | D010510 | 15 associated lipids |
| Osteitis Deformans | D010001 | 3 associated lipids |
| Dental Pulp Necrosis | D003790 | 6 associated lipids |
| Crohn Disease | D003424 | 12 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Gruber R | Cell biology of osteoimmunology. | 2010 | Wien Med Wochenschr | pmid:20714814 |
| Gajewska J et al. | [The impairement of bone formation and resorption in 25-year-old man with neglected celiac disease]. | 2005 | Wiad. Lek. | pmid:16238129 |
| Sobańska I et al. | [The influence of sex and age on the osteoprotegerin level in the blood]. | 2007 | Wiad. Lek. | pmid:17966895 |
| Ivanov SD et al. | [Prognosis of efficacy of organ-saving treatment of invasive bladder cancer]. | 2006 | Vopr Onkol | pmid:17168368 |
| Ito S and Hata T | Crystal structure of RANK ligand involved in bone metabolism. | 2004 | Vitam. Horm. | pmid:15110169 |
| Hao C et al. | Modulation of TRAIL signaling complex. | 2004 | Vitam. Horm. | pmid:15110173 |
| Ito R et al. | Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma. | 2003 | Virchows Arch. | pmid:12838418 |
| Gibbons CL et al. | Osteoclast-like cells in soft tissue leiomyosarcomas. | 2010 | Virchows Arch. | pmid:20127110 |
| Gu JH et al. | Effects of RANKL, osteoprotegerin, calcium and phosphorus on survival and activation of Muscovy duck osteoclasts in vitro. | 2009 | Vet. J. | pmid:18682334 |
| Elders RC et al. | Susceptibility of the C2 canine mastocytoma cell line to the effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). | 2009 | Vet. Immunol. Immunopathol. | pmid:19185923 |
| Booij-Vrieling HE et al. | Inflammatory cytokines and the nuclear vitamin D receptor are implicated in the pathophysiology of dental resorptive lesions in cats. | 2009 | Vet. Immunol. Immunopathol. | pmid:19556012 |
| Spahni AI et al. | Immunohistochemical localization of RANK, RANKL and OPG in healthy and arthritic canine elbow joints. | 2009 | Vet Surg | pmid:19674422 |
| Benevolenskaia LI | [Issues of osteoporosis in present-day medicine]. | 2003 | Vestn. Akad. Med. Nauk SSSR | pmid:12934464 |
| Shumakov VI et al. | [The peculiarities of bone exchange disorder and its regulation in men after long terms following orthotopic heart transplantation and cadaveric kidney transplantation]. | 2006 | Vestn. Akad. Med. Nauk SSSR | pmid:17136849 |
| Muehling B et al. | Effect of statin therapy on serum activity of proteinases and cytokines in patients with abdominal aortic aneurysm. | 2008 | Vasc Health Risk Manag | pmid:19337556 |
| Brown JM et al. | Osteoprotegerin and rank ligand expression in prostate cancer. | 2001 | Urology | pmid:11306358 |
| Sauer G et al. | [Pathophysiology of bone metastases in urologic carcinomas]. | 2007 | Urologe A | pmid:17632696 |
| Hayton MJ et al. | Involvement of adenosine 5'-triphosphate in ultrasound-induced fracture repair. | 2005 | Ultrasound Med Biol | pmid:16085103 |
| Renno AC et al. | Ultrasound therapy modulates osteocalcin expression during bone repair in rats. | 2012 | Ultrasonics | pmid:21820693 |
| Horshuns'ka MIu et al. | [Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus]. | 2013 May-Jun | Ukr Biokhim Zh (1999) | pmid:23937044 |
| Stilgren LS et al. | [The cytokine system of bone tissue]. | 2005 | Ugeskr. Laeg. | pmid:15789838 |
| Wada T et al. | RANKL-RANK signaling in osteoclastogenesis and bone disease. | 2006 | Trends Mol Med | pmid:16356770 |
| Nakashima T et al. | New insights into osteoclastogenic signaling mechanisms. | 2012 | Trends Endocrinol. Metab. | pmid:22705116 |
| Günther T and Schinke T | Mouse genetics have uncovered new paradigms in bone biology. | 2000 | Trends Endocrinol. Metab. | pmid:10856921 |
| Scatena M and Giachelli C | The alpha(v)beta3 integrin, NF-kappaB, osteoprotegerin endothelial cell survival pathway. Potential role in angiogenesis. | 2002 | Trends Cardiovasc. Med. | pmid:11852256 |
| Ricci P et al. | Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation. | 2006 | Transplantation | pmid:17164716 |
| Meneghini M et al. | Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation. | 2013 | Transplantation | pmid:23812001 |
| Hu H et al. | Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. | 2009 | Transplantation | pmid:19543058 |
| Bargnoux AS et al. | Renal transplantation decreases osteoprotegerin levels. | 2006 | Transplant. Proc. | pmid:16980077 |
| Malyszko J et al. | Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients. | 2003 | Transplant. Proc. | pmid:14529897 |
| Mesquita M et al. | Osteoprotegerin and progression of coronary and aortic calcifications in chronic kidney disease. | 2010 | Transplant. Proc. | pmid:21094794 |
| Bilgir O et al. | Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever. | 2012 | Transfus. Apher. Sci. | pmid:22079264 |
| Brzóska MM and Rogalska J | Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats. | 2013 | Toxicol. Appl. Pharmacol. | pmid:23726800 |
| Park SY et al. | Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment. | 2014 | Toxicol. Appl. Pharmacol. | pmid:24463094 |
| Yuksel S et al. | Increased serum osteoprotegerin levels associated with decreased bone mineral density in familial Mediterranean fever. | 2009 | Tohoku J. Exp. Med. | pmid:19346738 |
| Hsu BG et al. | High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients. | 2015 | Tohoku J. Exp. Med. | pmid:26156285 |
| Zheng CM et al. | Association between increased serum osteoprotegerin levels and improvement in bone mineral density after parathyroidectomy in hemodialysis patients. | 2012 | Tohoku J. Exp. Med. | pmid:22156488 |
| Whitney MJ et al. | Leukemia inhibitory factor secretion is a predictor and indicator of early progenitor status in adult bone marrow stromal cells. | 2009 | Tissue Eng Part A | pmid:18637760 |
| Tortelli F et al. | Osteoblast and osteoclast differentiation in an in vitro three-dimensional model of bone. | 2009 | Tissue Eng Part A | pmid:19292676 |
| Palumbo S and Li WJ | Osteoprotegerin enhances osteogenesis of human mesenchymal stem cells. | 2013 | Tissue Eng Part A | pmid:23597005 |
| Lin TH et al. | NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. | 2015 | Tissue Eng Part A | pmid:25518013 |
| Hasegawa T et al. | Human periodontal ligament cells derived from deciduous teeth induce osteoclastogenesis in vitro. | 2002 | Tissue Cell | pmid:11989970 |
| Carda C et al. | Osteoprotegerin (OPG) and RANKL expression and distribution in developing human craniomandibular joint. | 2005 | Tissue Cell | pmid:15899507 |
| Mikosch P et al. | High cathepsin K levels in men with differentiated thyroid cancer on suppressive L-thyroxine therapy. | 2008 | Thyroid | pmid:18302515 |
| Martini G et al. | The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels. | 2008 | Thyroid | pmid:18399769 |
| Vinholt PJ et al. | An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma. | 2013 | Thromb. Res. | pmid:23531238 |
| Guldiken B et al. | Serum osteoprotegerin levels in patients with acute atherothrombotic stroke and lacunar infarct. | 2007 | Thromb. Res. | pmid:17258300 |
| Hyseni A et al. | Chronic dysfunction of the endothelium is associated with mortality in acute coronary syndrome patients. | 2013 | Thromb. Res. | pmid:23273402 |
| Vik A et al. | Serum osteoprotegerin and future risk of venous thromboembolism. The Tromsø study. | 2012 | Thromb. Res. | pmid:22909822 |
| O'Sullivan EP et al. | Osteoprotegerin is higher in peripheral arterial disease regardless of glycaemic status. | 2010 | Thromb. Res. | pmid:20932553 |
| Al-Fakhri N et al. | Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-kappaB ligand (RANKL) in heterotopic vascular ossification. | 2005 | Thromb. Haemost. | pmid:16411417 |
| Vik A et al. | Heparin induces mobilization of osteoprotegerin into the circulation. | 2007 | Thromb. Haemost. | pmid:17598007 |
| Vik A et al. | Serum osteoprotegerin in young survivors of myocardial infarction. | 2006 | Thromb. Haemost. | pmid:16676081 |
| Hofbauer LC et al. | Interleukin-4 differentially regulates osteoprotegerin expression and induces calcification in vascular smooth muscle cells. | 2006 | Thromb. Haemost. | pmid:16601843 |
| Kees M et al. | Elevated plasma osteoprotegerin levels are associated with venous thrombosis and bleeding in patients with polycythemia vera. | 2005 | Thromb. Haemost. | pmid:15630493 |
| Celińska-Löwenhoff M et al. | Effects of hypolipemic drugs on the osteoprotegerin - sRANKL system in patients with coronary artery disease. | 2007 | Thromb. Haemost. | pmid:17479201 |
| Brandenburg V et al. | Calcification inhibitors in vascular calciphylaxis associated with normal renal function. | 2012 | Thromb. Haemost. | pmid:23092963 |
| Hess U | [The plasma cell myeloma--molecular pathogenesis and target therapies]. | 2006 | Ther Umsch | pmid:16689452 |
| Yokoyama K et al. | Low blood osteoprotegerin levels are a predictor to poor prognosis in Japanese patients on hemodialysis due to diabetic nephropathy. | 2008 | Ther Apher Dial | pmid:18503706 |
| Doumouchtsis K et al. | Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease. | 2009 | Ther Apher Dial | pmid:19379170 |
| Chasseraud M et al. | Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification. | 2011 | Ther Apher Dial | pmid:21426505 |
| Kazama JJ et al. | Circulating osteoprotegerin affects bone metabolism in dialysis patients with mild secondary hyperparathyroidism. | 2006 | Ther Apher Dial | pmid:16817791 |
| Doi S et al. | Increased serum osteoprotegerin level in older and diabetic hemodialysis patients. | 2004 | Ther Apher Dial | pmid:15274686 |
| Rashtchizadeh N et al. | Serum receptor activator of nuclear factor-κ B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patients. | 2012 | Ther Apher Dial | pmid:23190522 |
| Dzgoeva FU et al. | [Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease]. | 2014 | Ter. Arkh. | pmid:25095658 |
| Kochetkova EA et al. | [Osteoprotegerin and bone mineral density in patients with chronic obstructive pulmonary disease]. | 2010 | Ter. Arkh. | pmid:20873238 |
| Hazenberg JG et al. | Microdamage detection and repair in bone: fracture mechanics, histology, cell biology. | 2009 | Technol Health Care | pmid:19478407 |
| Suda T et al. | [Merger of bone biology and immunology]. | 2002 | Tanpakushitsu Kakusan Koso | pmid:12385106 |
| Straface G et al. | Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability. | 2011 | Stroke | pmid:21903966 |
| Golledge J et al. | Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. | 2004 | Stroke | pmid:15143295 |
| Grzibovskis M et al. | Specific signaling molecule expressions in the interradicular septum in different age groups. | 2011 | Stomatologija | pmid:22071415 |
| Farach-Carson MC et al. | Integrating rapid responses to 1,25-dihydroxyvitamin D3 with transcriptional changes in osteoblasts: Ca2+ regulated pathways to the nucleus. | 2004 | Steroids | pmid:15288767 |
| Allan GF et al. | Induction of the progesterone receptor gene in estrogen target cells monitored by branched DNA signal amplification. | 2001 | Steroids | pmid:11546554 |
| Bashir A et al. | Changes in RANKL/OPG/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene. | 2005 | Steroids | pmid:16005483 |
| Board-Davies E et al. | Oral Mucosal Lamina Propria-Progenitor Cells Exert Antibacterial Properties via the Secretion of Osteoprotegerin and Haptoglobin. | 2015 | Stem Cells Transl Med | pmid:26378260 |
| Liu M et al. | Curculigoside improves osteogenesis of human amniotic fluid-derived stem cells. | 2014 | Stem Cells Dev. | pmid:24007307 |
| Zhu H et al. | Tumor necrosis factor-alpha alters the modulatory effects of mesenchymal stem cells on osteoclast formation and function. | 2009 | Stem Cells Dev. | pmid:19374589 |
| Li B et al. | Periodontal ligament stem cells modulate root resorption of human primary teeth via Runx2 regulating RANKL/OPG system. | 2014 | Stem Cells Dev. | pmid:24827498 |
| Su F et al. | Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells. | 2015 | Stem Cell Res Ther | pmid:25888745 |
| Cong Q et al. | p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. | 2016 | Stem Cell Reports | pmid:26947973 |
| Olivares-Navarrete R et al. | Rough titanium alloys regulate osteoblast production of angiogenic factors. | 2013 | Spine J | pmid:23684238 |
| Coetzee M and Kruger MC | Osteoprotegerin-receptor activator of nuclear factor-kappaB ligand ratio: a new approach to osteoporosis treatment? | 2004 | South. Med. J. | pmid:15180028 |
| Sun C et al. | [Acqusition of full-length gene for rabbit osteoprotegerin]. | 2012 | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | pmid:22404020 |
| Zhang B et al. | [Molecular mechanism of bone absorption in osteoclast]. | 2005 | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | pmid:16422121 |
| Zhou J et al. | [Effect of sinusoidal electromagnetic fields on rats femur tissue cultivation in vitro]. | 2013 | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | pmid:23865319 |
| Liu JZ et al. | [The OPG/RANKL/RANK system and bone resorptive disease]. | 2003 | Sheng Wu Gong Cheng Xue Bao | pmid:15971575 |
| Liu JZ et al. | [Construction and biological activity study of human osteoprotegerin expressing adenoviral system]. | 2003 | Sheng Wu Gong Cheng Xue Bao | pmid:15969033 |
| Wang BL et al. | Recombinant soluble receptor activator of nuclear factor-kappaB inhibits parathyroid hormone-induced osteoclastogenesis in vitro. | 2007 | Sheng Li Xue Bao | pmid:17437039 |
| Duan XH et al. | [The endocrine function of the skeleton]. | 2010 | Sheng Li Ke Xue Jin Zhan | pmid:21416939 |
| Wang S and Liu YS | [Advance on arterial calcification]. | 2012 | Sheng Li Ke Xue Jin Zhan | pmid:23189619 |
| Zhou YQ et al. | [OPG and OPGL expression in condyle cartilage of temporomandibular joint following anterior disc displacement]. | 2005 | Shanghai Kou Qiang Yi Xue | pmid:16155701 |
| Hortobagyi GN | Novel approaches to the management of bone metastases. | 2003 | Semin. Oncol. | pmid:14613037 |
| Berenson JR | Advances in the biology and treatment of myeloma bone disease. | 2002 | Semin. Oncol. | pmid:12520479 |
| Wang AY | Consequences of chronic inflammation in peritoneal dialysis. | 2011 | Semin. Nephrol. | pmid:21439430 |
| Hruska KA et al. | Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy. | 2004 | Semin. Nephrol. | pmid:14730507 |
| Josson S et al. | Tumor-stroma co-evolution in prostate cancer progression and metastasis. | 2010 | Semin. Cell Dev. Biol. | pmid:19948237 |
| Daoussis D et al. | Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis. | 2010 | Semin. Arthritis Rheum. | pmid:19095294 |
| Schlieper G et al. | Inhibitors of calcification in blood and urine. | 2007 Mar-Apr | Semin Dial | pmid:17374084 |
| Yasuda H | [A new paradigm of osteoclast biology: discovery of OCIF and ODF]. | 2000 | Seikagaku | pmid:10967683 |
| Takayanagi H | [Signaling mechanism in the regulation of osteoclast differentiation by the immune system]. | 2003 | Seikagaku | pmid:14748148 |